Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2020

01-11-2020 | Care | Original Research

Rethinking How We Measure Costs in Implementation Research

Author: Todd H. Wagner, PhD

Published in: Journal of General Internal Medicine | Special Issue 2/2020

Login to get access

Abstract

Background

Hospitals and other health care delivery organizations are sometimes resistant to implementing evidence‐based programs, citing unknown budgetary implications.

Objective

In this paper, I discuss challenges when estimating health care costs in implementation research.

Design

A case study with intensive care units highlights how including fixed costs can cloud a short‐term analysis.

Participants

None.

Interventions

None.

Main Measures

Health care costs, charges and payments.

Key Results

Cost data should accurately reflect the opportunity costs for the organization(s) providing care. Opportunity costs are defined as the benefits foregone because the resources were not used in the next best alternative. Because there is no database of opportunity costs, cost studies rely on accounting data, charges, or payments as proxies. Unfortunately, these proxies may not reflect the organization’s opportunity costs, especially if the goal is to understand the budgetary impact in the next few years.

Conclusions

Implementation researchers should exclude costs that are fixed in the time period of observation because these assets (e.g., space) cannot be used in the next best alternative. In addition, it is common to use costs from accounting databases where we implicitly assume health care providers are uniformly efficient. If providers are not operating efficiently, especially if there is variation in their efficiency, then this can create further problems. Implementation scientists should be judicious in their use of cost estimates from accounting data, otherwise research results can misguide decision makers.
Literature
1.
go back to reference Owens DK, Qaseem A, Chou R, Shekelle P. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174-180.CrossRef Owens DK, Qaseem A, Chou R, Shekelle P. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174-180.CrossRef
2.
go back to reference Neumann P, Sanders G, Russell L, Siegel J, Ganiats T, eds. Cost-effectiveness in Health and Medicine. Oxford University Press; 2016. Neumann P, Sanders G, Russell L, Siegel J, Ganiats T, eds. Cost-effectiveness in Health and Medicine. Oxford University Press; 2016.
3.
go back to reference Tan-Torres Edejer T, Baltussen R, Adam T, et al., eds. WHO Guide to Cost Effectiveness Analysis. Geneva, Switzerland: World Health Oranization; 2003. Tan-Torres Edejer T, Baltussen R, Adam T, et al., eds. WHO Guide to Cost Effectiveness Analysis. Geneva, Switzerland: World Health Oranization; 2003.
4.
go back to reference Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476-481.PubMed Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476-481.PubMed
5.
go back to reference Palmer S, Raftery J. Economic Notes: opportunity cost. Br Med J. 1999;318(7197):1551-1552.CrossRef Palmer S, Raftery J. Economic Notes: opportunity cost. Br Med J. 1999;318(7197):1551-1552.CrossRef
6.
go back to reference Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press; 1996. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press; 1996.
7.
go back to reference Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating Costs in Cost Effectiveness Analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996:176-213. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating Costs in Cost Effectiveness Analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996:176-213.
8.
go back to reference Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis. In: Neuman P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 2016:201-235.CrossRef Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis. In: Neuman P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 2016:201-235.CrossRef
9.
go back to reference Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med. 2010;38(1):65-71.CrossRef Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med. 2010;38(1):65-71.CrossRef
10.
go back to reference Gooch RA, Kahn JM. ICU bed supply, utilization, and health care spending: an example of demand elasticity. JAMA. 2014;311(6):567-568.CrossRef Gooch RA, Kahn JM. ICU bed supply, utilization, and health care spending: an example of demand elasticity. JAMA. 2014;311(6):567-568.CrossRef
11.
go back to reference Chen LM, Render M, Sales A, Kennedy EH, Wiitala W, Hofer TP. Intensive care unit admitting patterns in the Veterans Affairs health care system. Arch Intern Med. 2012;172(16):1220-1226.CrossRef Chen LM, Render M, Sales A, Kennedy EH, Wiitala W, Hofer TP. Intensive care unit admitting patterns in the Veterans Affairs health care system. Arch Intern Med. 2012;172(16):1220-1226.CrossRef
12.
go back to reference Chang DW, Dacosta D, Shapiro MF. Priority Levels in Medical Intensive Care at an Academic Public Hospital. JAMA Intl Med. 2017;177(2):280-281.CrossRef Chang DW, Dacosta D, Shapiro MF. Priority Levels in Medical Intensive Care at an Academic Public Hospital. JAMA Intl Med. 2017;177(2):280-281.CrossRef
13.
go back to reference Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33(6):1266-1271.CrossRef Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33(6):1266-1271.CrossRef
14.
go back to reference Chiou H, Jopling JK, Scott JY, et al. Detecting organisational innovations leading to improved ICU outcomes: a protocol for a double-blinded national positive deviance study of critical care delivery. BMJ Open. 2017;7(6):e015930.CrossRef Chiou H, Jopling JK, Scott JY, et al. Detecting organisational innovations leading to improved ICU outcomes: a protocol for a double-blinded national positive deviance study of critical care delivery. BMJ Open. 2017;7(6):e015930.CrossRef
15.
go back to reference Arrow K. Uncertainty and the welfare economics of medical care. AER. 1963;53(5):941-973. Arrow K. Uncertainty and the welfare economics of medical care. AER. 1963;53(5):941-973.
16.
go back to reference Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16(1):1-31.CrossRef Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16(1):1-31.CrossRef
17.
go back to reference Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716-721.CrossRef Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716-721.CrossRef
18.
go back to reference Drummond MF, O’Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Second Edition ed. Oxford: Oxford University Press; 1997. Drummond MF, O’Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Second Edition ed. Oxford: Oxford University Press; 1997.
19.
go back to reference Bryan S, Mitton C, Donaldson C. Breaking the addiction to technology adoption. Health Econ. 2014;23(4):379-383.CrossRef Bryan S, Mitton C, Donaldson C. Breaking the addiction to technology adoption. Health Econ. 2014;23(4):379-383.CrossRef
20.
go back to reference Hwang J, Christensen CM. Disruptive innovation in health care delivery: a framework for business-model innovation. Health Aff. 2008;27(5):1329-1335.CrossRef Hwang J, Christensen CM. Disruptive innovation in health care delivery: a framework for business-model innovation. Health Aff. 2008;27(5):1329-1335.CrossRef
21.
go back to reference Humphreys K, Wagner TH, Gage M. If substance use disorder treatment more than offsets its costs, why don’t more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. J Subst Abuse Treat. 2011;41(3):243-251.CrossRef Humphreys K, Wagner TH, Gage M. If substance use disorder treatment more than offsets its costs, why don’t more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. J Subst Abuse Treat. 2011;41(3):243-251.CrossRef
22.
go back to reference Ettner SL, Huang D, Evans E, et al. Benefit-cost in the California treatment outcome project: does substance abuse treatment “pay for itself”? Health Serv Res. 2006;41(1):192-213.CrossRef Ettner SL, Huang D, Evans E, et al. Benefit-cost in the California treatment outcome project: does substance abuse treatment “pay for itself”? Health Serv Res. 2006;41(1):192-213.CrossRef
23.
go back to reference Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis In: Neumann P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. Oxford University Press; 2016. Basu A. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis In: Neumann P, Sanders G, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine. Oxford University Press; 2016.
24.
go back to reference Barnett PG. An improved set of standards for finding cost for cost-effectiveness analysis. Med Care. 2009;47(7 Suppl 1):S82-88.CrossRef Barnett PG. An improved set of standards for finding cost for cost-effectiveness analysis. Med Care. 2009;47(7 Suppl 1):S82-88.CrossRef
25.
go back to reference Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89(9):46-52, 54, 56-61 passim.PubMed Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89(9):46-52, 54, 56-61 passim.PubMed
26.
go back to reference Adang EM, Wensing M. Economic barriers to implementation of innovations in health care: is the long run-short run efficiency discrepancy a paradox? Health Policy. 2008;88(2-3):236-242.CrossRef Adang EM, Wensing M. Economic barriers to implementation of innovations in health care: is the long run-short run efficiency discrepancy a paradox? Health Policy. 2008;88(2-3):236-242.CrossRef
27.
go back to reference Valdmanis VG, Rosko MD, Mutter RL. Hospital quality, efficiency, and input slack differentials. Health Serv Res. 2008;43(5 Pt 2):1830-1848.CrossRef Valdmanis VG, Rosko MD, Mutter RL. Hospital quality, efficiency, and input slack differentials. Health Serv Res. 2008;43(5 Pt 2):1830-1848.CrossRef
28.
go back to reference Bloom N, Van Reenen J. Measuring and Explaining Management Practices Across Firms and Countries. Q J Econ. 2007;122(4):1351-1408.CrossRef Bloom N, Van Reenen J. Measuring and Explaining Management Practices Across Firms and Countries. Q J Econ. 2007;122(4):1351-1408.CrossRef
29.
go back to reference Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med. 2000;132(12):964-972.CrossRef Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med. 2000;132(12):964-972.CrossRef
30.
go back to reference Mauskopf J, Sullivan S, Annemans L. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis. Value Health. 2007;10:336-347.CrossRef Mauskopf J, Sullivan S, Annemans L. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis. Value Health. 2007;10:336-347.CrossRef
31.
go back to reference Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5-14.CrossRef Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014;17(1):5-14.CrossRef
32.
go back to reference Roberts SLE, Healey A, Sevdalis N. Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review. Implement Sci. 2019;14(1):72.CrossRef Roberts SLE, Healey A, Sevdalis N. Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review. Implement Sci. 2019;14(1):72.CrossRef
33.
go back to reference Reeves P, Edmunds K, Searles A, Wiggers J. Economic evaluations of public health implementation-interventions: a systematic review and guideline for practice. Public Health. 2019;169:101-113.CrossRef Reeves P, Edmunds K, Searles A, Wiggers J. Economic evaluations of public health implementation-interventions: a systematic review and guideline for practice. Public Health. 2019;169:101-113.CrossRef
34.
go back to reference Dopp AR, Mundey P, Beasley LO, Silovsky JF, Eisenberg D. Mixed-method approaches to strengthen economic evaluations in implementation research. Implement Sci. 2019;14(1):2.CrossRef Dopp AR, Mundey P, Beasley LO, Silovsky JF, Eisenberg D. Mixed-method approaches to strengthen economic evaluations in implementation research. Implement Sci. 2019;14(1):2.CrossRef
35.
go back to reference Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, D.C.: The National Academies Press; 2012. Institute of Medicine, ed. Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, D.C.: The National Academies Press; 2012. Institute of Medicine, ed.
Metadata
Title
Rethinking How We Measure Costs in Implementation Research
Author
Todd H. Wagner, PhD
Publication date
01-11-2020
Publisher
Springer International Publishing
Keyword
Care
Published in
Journal of General Internal Medicine / Issue Special Issue 2/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06104-6

Other articles of this Special Issue 2/2020

Journal of General Internal Medicine 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.